Synthetic corticosteroids as tryptophan hydroxylase stabilizers

Future Med Chem. 2021 Sep;13(17):1465-1474. doi: 10.4155/fmc-2021-0068. Epub 2021 Jul 12.

Abstract

Background: Clinically, corticosteroids are used mainly for their immune-modulatory properties but are also known to influence mood. Despite evidence of a role in regulating tryptophan hydroxylases (TPH), key enzymes in serotonin biosynthesis, a direct action of corticosteroids on these enzymes has not been systematically investigated. Methodology & results: Corticosteroid effects on TPHs were tested using an in vitro assay. The compound with the strongest modulatory effect, beclomethasone dipropionate, activated TPH1 and TPH2 with low micromolar potency. Thermostability assays suggested a stabilizing mechanism, and computational docking indicated that beclomethasone dipropionate interacts with the TPH active site. Conclusion: Beclomethasone dipropionate is a stabilizer of TPHs, acting as a pharmacological chaperone. Our findings may inspire further development of steroid scaffolds as putative antidepressant drugs.

Keywords: aromatic amino acid hydroxylases; enzyme assay; molecular docking analysis; pharmacological chaperone; serotonin; stabilizer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex Hormones / chemical synthesis
  • Adrenal Cortex Hormones / chemistry
  • Adrenal Cortex Hormones / pharmacology*
  • Catalytic Domain / drug effects
  • Enzyme Stability
  • Humans
  • Molecular Conformation
  • Molecular Docking Simulation
  • Tryptophan Hydroxylase / metabolism*

Substances

  • Adrenal Cortex Hormones
  • Tryptophan Hydroxylase